APNHF
Price
$7.25
Change
-$4.99 (-40.77%)
Updated
Jun 6 closing price
Capitalization
2.6B
ORXOY
Price
$1.91
Change
-$0.09 (-4.50%)
Updated
Aug 15 closing price
Capitalization
74.6M
Interact to see
Advertisement

APNHF vs ORXOY

Header iconAPNHF vs ORXOY Comparison
Open Charts APNHF vs ORXOYBanner chart's image
Aspen Pharmacare Holdings
Price$7.25
Change-$4.99 (-40.77%)
Volume$407
Capitalization2.6B
Orexo AB
Price$1.91
Change-$0.09 (-4.50%)
Volume$630
Capitalization74.6M
APNHF vs ORXOY Comparison Chart in %
Loading...
APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORXOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APNHF vs. ORXOY commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHF is a Hold and ORXOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (APNHF: $7.25 vs. ORXOY: $1.91)
Brand notoriety: APNHF and ORXOY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: APNHF: 100% vs. ORXOY: 64%
Market capitalization -- APNHF: $2.65B vs. ORXOY: $74.6M
APNHF [@Pharmaceuticals: Generic] is valued at $2.65B. ORXOY’s [@Pharmaceuticals: Generic] market capitalization is $74.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.78B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHF’s FA Score shows that 1 FA rating(s) are green whileORXOY’s FA Score has 0 green FA rating(s).

  • APNHF’s FA Score: 1 green, 4 red.
  • ORXOY’s FA Score: 0 green, 5 red.
According to our system of comparison, both APNHF and ORXOY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHF’s TA Score shows that 2 TA indicator(s) are bullish while ORXOY’s TA Score has 4 bullish TA indicator(s).

  • APNHF’s TA Score: 2 bullish, 0 bearish.
  • ORXOY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both APNHF and ORXOY are a good buy in the short-term.

Price Growth

APNHF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ORXOY (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.87%. For the same industry, the average monthly price growth was +11.08%, and the average quarterly price growth was +76.49%.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.87% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHF($2.6B) has a higher market cap than ORXOY($74.6M). ORXOY YTD gains are higher at: 1.326 vs. APNHF (-40.792). APNHF has higher annual earnings (EBITDA): 8.02B vs. ORXOY (33.5M). APNHF has more cash in the bank: 6.8B vs. ORXOY (121M). ORXOY has less debt than APNHF: ORXOY (496M) vs APNHF (35.5B). APNHF has higher revenues than ORXOY: APNHF (45.5B) vs ORXOY (561M).
APNHFORXOYAPNHF / ORXOY
Capitalization2.6B74.6M3,483%
EBITDA8.02B33.5M23,946%
Gain YTD-40.7921.326-3,076%
P/E Ratio12.54N/A-
Revenue45.5B561M8,111%
Total Cash6.8B121M5,623%
Total Debt35.5B496M7,157%
FUNDAMENTALS RATINGS
APNHF vs ORXOY: Fundamental Ratings
APNHF
ORXOY
OUTLOOK RATING
1..100
4396
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8843
P/E GROWTH RATING
1..100
89100
SEASONALITY SCORE
1..100
3150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHF's Valuation (13) in the null industry is somewhat better than the same rating for ORXOY (76). This means that APNHF’s stock grew somewhat faster than ORXOY’s over the last 12 months.

APNHF's Profit vs Risk Rating (100) in the null industry is in the same range as ORXOY (100). This means that APNHF’s stock grew similarly to ORXOY’s over the last 12 months.

APNHF's SMR Rating (99) in the null industry is in the same range as ORXOY (100). This means that APNHF’s stock grew similarly to ORXOY’s over the last 12 months.

ORXOY's Price Growth Rating (43) in the null industry is somewhat better than the same rating for APNHF (88). This means that ORXOY’s stock grew somewhat faster than APNHF’s over the last 12 months.

APNHF's P/E Growth Rating (89) in the null industry is in the same range as ORXOY (100). This means that APNHF’s stock grew similarly to ORXOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APNHFORXOY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
26%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
50%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
20%
Bullish Trend 2 days ago
29%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
21%
Bearish Trend 2 days ago
36%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
27%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
APNHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORXOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNGCF0.17N/A
+0.78%
Sanu Gold Corp.
AFMJF0.76N/A
+0.37%
Alphamin Resources Corp.
CBSC0.04N/A
N/A
Cardiac Biotech Solutions Inc.
SGBAF6.85N/A
N/A
SES SA
ADDDF196.62-0.88
-0.45%
adidas AG

APNHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, APNHF has been loosely correlated with GEDSF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if APNHF jumps, then GEDSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHF
1D Price
Change %
APNHF100%
N/A
GEDSF - APNHF
51%
Loosely correlated
N/A
MSTH - APNHF
39%
Loosely correlated
N/A
ORXOY - APNHF
29%
Poorly correlated
N/A
INNPF - APNHF
20%
Poorly correlated
-0.55%
QNTM - APNHF
4%
Poorly correlated
-2.10%
More

ORXOY and

Correlation & Price change

A.I.dvisor tells us that ORXOY and APNHF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORXOY and APNHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORXOY
1D Price
Change %
ORXOY100%
N/A
APNHF - ORXOY
28%
Poorly correlated
N/A
TKNO - ORXOY
8%
Poorly correlated
-5.68%
SEHCF - ORXOY
5%
Poorly correlated
N/A
GLASF - ORXOY
4%
Poorly correlated
+0.38%
HTSUY - ORXOY
0%
Poorly correlated
N/A
More